{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:30:23Z","timestamp":1779258623403,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["SA264P18"],"award-info":[{"award-number":["SA264P18"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["CIVP19A5942"],"award-info":[{"award-number":["CIVP19A5942"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["CB16\/12\/00352"],"award-info":[{"award-number":["CB16\/12\/00352"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["EPAEC222641CICS"],"award-info":[{"award-number":["EPAEC222641CICS"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["CLC-2017-01"],"award-info":[{"award-number":["CLC-2017-01"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/0153"],"award-info":[{"award-number":["PI22\/0153"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HRAS<jats:sup>KO<\/jats:sup>\/NRAS<jats:sup>KO<\/jats:sup> double knockout mice exhibit exceedingly high rates of perinatal lethality due to respiratory failure caused by a significant lung maturation delay. The few animals that reach adulthood have a normal lifespan, but present areas of atelectasis mixed with patches of emphysema and normal tissue in the lung.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eight double knockout and eight control mice were analyzed using micro-X-ray computerized tomography and a Small Animal Physiological Monitoring system. Tissues and samples from these mice were analyzed using standard histological and Molecular Biology methods and the significance of the results analyzed using a Student\u00b4s T-test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The very few double knockout mice surviving up to adulthood display clear craniofacial abnormalities reminiscent of those seen in RASopathy mouse models, as well as thrombocytopenia, bleeding anomalies, and reduced platelet activation induced by thrombin. These surviving mice also present heart and spleen hyperplasia, and elevated numbers of myeloid-derived suppressor cells in the spleen. Mechanistically, we observed that these phenotypic alterations are accompanied by increased KRAS-GTP levels in heart, platelets and primary mouse embryonic fibroblasts from these animals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data uncovers a new, previously unidentified mechanism capable of triggering a RASopathy phenotype in mice as a result of the combined removal of HRAS and NRAS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12964-024-01717-4","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T15:01:57Z","timestamp":1718636517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined HRAS and NRAS ablation induces a RASopathy phenotype in mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Roc\u00edo","family":"Fuentes-Mateos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3sula","family":"Garc\u00eda-Navas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Infante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Hern\u00e1ndez-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Calzada-Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Olarte-San","family":"Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Fern\u00e1ndez-Medarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"1717_CR1","doi-asserted-by":"crossref","unstructured":"Rauen KA. The RASopathies. Annu. Rev. Genomics Hum. Genet. Annual Reviews; 2013. p. 355\u201369. Available from: https:\/\/www.annualreviews.org\/doi\/abs\/10.1146\/annurev-genom-091212-153523","DOI":"10.1146\/annurev-genom-091212-153523"},{"key":"1717_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bj.2021.06.004","volume":"44","author":"Q Riller","year":"2021","unstructured":"Riller Q, Rieux-Laucat F. RASopathies: from germline mutations to somatic and multigenic diseases. Biomed J. 2021;44:422\u201332 Elsevier.","journal-title":"Biomed J"},{"issue":"2","key":"1717_CR3","doi-asserted-by":"publisher","first-page":"188445","DOI":"10.1016\/j.bbcan.2020.188445","volume":"1874","author":"FC Baltan\u00e1s","year":"2020","unstructured":"Baltan\u00e1s FC, Zarich N, Rojas-Caba\u00f1eros JM, Santos E. SOS GEFs in health and disease. Biochim Biophys Acta - Rev Cancer. 2020;1874(2):188445 Elsevier.","journal-title":"Biochim Biophys Acta - Rev Cancer."},{"key":"1717_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1947601911411084","volume":"2","author":"A Fern\u00e1ndez-Medarde","year":"2011","unstructured":"Fern\u00e1ndez-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer. 2011;2:344\u201358.","journal-title":"Genes Cancer"},{"key":"1717_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1947601911408081","volume":"2","author":"E Castellano","year":"2011","unstructured":"Castellano E, Santos E. Functional specificity of Ras isoforms: So similar but so different. Genes Cancer. 2011;2:216\u201331.","journal-title":"Genes Cancer"},{"key":"1717_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1210\/er.2017-00232","volume":"39","author":"M Tajan","year":"2018","unstructured":"Tajan M, Paccoud R, Branka S, Edouard T, Yart A. The RASopathy family: consequences of germline activation of the RAS\/MAPK pathway. Endocr Rev. 2018;39:676\u2013700. https:\/\/doi.org\/10.1210\/er.2017-00232.","journal-title":"Endocr Rev"},{"key":"1717_CR7","doi-asserted-by":"crossref","unstructured":"Bellio M, Garcia C, Edouard T, Voisin S, Neel BG, Cabou C, et al. Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions. Blood. 2019;134:2304\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31562133\/","DOI":"10.1182\/blood.2019001543"},{"key":"1717_CR8","doi-asserted-by":"crossref","unstructured":"Siano MA, Marchetti V, Pagano S, Di Candia F, Alessio M, De Brasi D, et al. Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity. Orphanet J Rare Dis. 2021;16:1\u20138. Available from:https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02050-6","DOI":"10.1186\/s13023-021-02050-6"},{"key":"1717_CR9","doi-asserted-by":"crossref","unstructured":"Blanchard-Rohner G, Ragotte RJ, Junker AK, Sharma M, Del Bel KL, Lu HY, et al. Idiopathic splenomegaly in childhood and the spectrum of RAS-associated lymphoproliferative disease: a case report. BMC Pediatr. 2021;21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7819237\/","DOI":"10.1186\/s12887-021-02508-3"},{"key":"1717_CR10","doi-asserted-by":"crossref","unstructured":"Yu KPT, Luk HM, Leung GKC, Mak CCY, Cheng SSW, Hau EWL, et al. Genetic landscape of RASopathies in Chinese: Three decades\u2019 experience in Hong Kong. Am J Med Genet Part C Semin Med Genet. 2019;181:208\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30896080\/","DOI":"10.1002\/ajmg.c.31692"},{"key":"1717_CR11","first-page":"121","volume":"48","author":"G Morcaldi","year":"2015","unstructured":"Morcaldi G, Bellini T, Rossi C, Maghnie M, Boccardo F, Bonioli E, et al. Lymphodysplasia and KRAS mutation: a case report and literature review. Lymphology. 2015;48:121\u20137.","journal-title":"Lymphology"},{"key":"1717_CR12","doi-asserted-by":"publisher","first-page":"e140495","DOI":"10.1172\/jci.insight.140495","volume":"5","author":"JC Wong","year":"2020","unstructured":"Wong JC, Perez-Mancera PA, Huang TQ, Kim J, Grego-Bessa J, del pilar Alzamora M, et al. KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice. JCI Insight. 2020;5:e140495.","journal-title":"JCI Insight"},{"key":"1717_CR13","doi-asserted-by":"crossref","unstructured":"Araki T, Mohi MG, Ismat FA, Bronson RT, Williams IR, Kutok JL, et al. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med. 2004;10:849\u201357. Available from: http:\/\/www.nature.com\/naturemedicine","DOI":"10.1038\/nm1084"},{"key":"1717_CR14","doi-asserted-by":"crossref","unstructured":"Kent OA, Saha M, Coyaud E, Burston HE, Law N, Dadson K, et al. Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes. Nat Commun 2020 111. 2020;11:1\u201312. Available from: https:\/\/www.nature.com\/articles\/s41467-020-18483-9","DOI":"10.1038\/s41467-020-18483-9"},{"key":"1717_CR15","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/ajmg.a.37655","volume":"170","author":"N Gomez-Ospina","year":"2016","unstructured":"Gomez-Ospina N, Kuo C, Ananth AL, Myers A, Brennan M-L, Stevenson DA, et al. Respiratory system involvement in Costello syndrome. Am J Med Genet A. 2016;170:1849\u201357.","journal-title":"Am J Med Genet A"},{"key":"1717_CR16","doi-asserted-by":"crossref","unstructured":"Myers A, Bernstein JA, Brennan ML, Curry C, Esplin ED, Fisher J, et al. Perinatal features of the RASopathies: Noonan syndrome, Cardiofaciocutaneous syndrome and Costello syndrome. Am J Med Genet Part A. 2014;164:2814\u201321. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ajmg.a.36737","DOI":"10.1002\/ajmg.a.36737"},{"key":"1717_CR17","doi-asserted-by":"crossref","unstructured":"Ratola A, Silva HM, Guedes A, Mota C, Braga AC, Oliveira D, et al. A novel Noonan syndrome RAF1 mutation: Lethal course in a preterm infant. Pediatr Rep. 2015;7:35\u20138. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4508625\/","DOI":"10.4081\/pr.2015.5955"},{"key":"1717_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1128\/MCB.21.5.1444-1452.2001","volume":"21","author":"LM Esteban","year":"2001","unstructured":"Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N, Yienger K, et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both Loci for mouse growth and development. Mol Cell Biol. 2001;21:1444\u201352.","journal-title":"Mol Cell Biol"},{"key":"1717_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41419-019-2075-2","volume":"10","author":"R Fuentes-Mateos","year":"2019","unstructured":"Fuentes-Mateos R, Jimeno D, G\u00f3mez C, Calzada N, Fern\u00e1ndez-Medarde A, Santos E. Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice. Cell Death Dis. 2019;10:838.","journal-title":"Cell Death Dis."},{"key":"1717_CR20","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Cano L, Fern\u00e1ndez-Infante C, Herranz \u00d3, Berrocal P, Lozano FS, S\u00e1nchez-Mart\u00edn MA, et al. New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance. Front Cell Dev Biol. 2022;10:1026287. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9661425\/","DOI":"10.3389\/fcell.2022.1026287"},{"key":"1717_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-020-0119-9","volume":"5","author":"S Guti\u00e9rrez-Herrero","year":"2020","unstructured":"Guti\u00e9rrez-Herrero S, Fern\u00e1ndez-Infante C, Hern\u00e1ndez-Cano L, Ortiz-Rivero S, Guijas C, Mart\u00edn-Granado V, et al. C3G contributes to platelet activation and aggregation by regulating major signaling pathways. Signal Transduct Target Ther. 2020;5:29. https:\/\/doi.org\/10.1038\/s41392-020-0119-9.","journal-title":"Signal Transduct Target Ther."},{"key":"1717_CR22","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1038\/onc.2016.169","volume":"35","author":"P Liceras-Boillos","year":"2016","unstructured":"Liceras-Boillos P, Garc\u00eda-Navas R, Ginel-Picardo A, Anta B, P\u00e9rez-Andr\u00e9s M, Lillo C, et al. Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs. Oncogene. 2016;35:6389\u2013402.","journal-title":"Oncogene"},{"key":"1717_CR23","first-page":"729","volume":"129","author":"D Jimeno","year":"2016","unstructured":"Jimeno D, G\u00f3mez C, Calzada N, de la Villa P, Lillo C, Santos E. RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors. J Cell Sci. 2016;129:729\u201342.","journal-title":"J Cell Sci"},{"key":"1717_CR24","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2022. Available from: https:\/\/www.r-project.org\/"},{"key":"1717_CR25","unstructured":"Urbanek S, Johnson K. Read and Write TIFF Images. 2022. Available from: https:\/\/cran.r-project.org\/package=tiff"},{"key":"1717_CR26","unstructured":"Urbanek S. jpeg: Read and write JPEG images. 2021. Available from: https:\/\/cran.r-project.org\/package=jpeg"},{"key":"1717_CR27","unstructured":"Weller H. colordistance: Distance Metrics for Image Color Similarity. 2021. Available from: https:\/\/cran.r-project.org\/package=colordistance"},{"key":"1717_CR28","doi-asserted-by":"crossref","unstructured":"Nakamura T, Gulick J, Pratt R, Robbins J. Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations. Proc Natl Acad Sci USA. 2009;106:15436\u201341. Available from: https:\/\/www.pnas.org\/content\/106\/36\/15436","DOI":"10.1073\/pnas.0903302106"},{"key":"1717_CR29","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Porras I, Fabbiano S, Schuhmacher AJ, Aicher A, Ca\u00f1amero M, C\u00e1mara JA, et al. K-RasV14I recapitulates Noonan syndrome in mice. Proc Natl Acad Sci. 2014;111:16395 LP \u2013 16400. Available from: http:\/\/www.pnas.org\/content\/111\/46\/16395.abstract","DOI":"10.1073\/pnas.1418126111"},{"key":"1717_CR30","doi-asserted-by":"crossref","unstructured":"Linglart L, Gelb BD. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment. Am J Med Genet Part C Semin Med Genet. 2020;184:73\u201380. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7682536\/","DOI":"10.1002\/ajmg.c.31765"},{"key":"1717_CR31","doi-asserted-by":"crossref","unstructured":"Delogu AB, Limongelli G, Versacci P, Adorisio R, Kaski JP, Blandino R, et al. The heart in RASopathies. Am. J. Med. Genet. Part C Semin. Med. Genet. John Wiley & Sons, Ltd; 2022. p. 440\u201351. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ajmg.c.32014","DOI":"10.1002\/ajmg.c.32014"},{"key":"1717_CR32","doi-asserted-by":"crossref","unstructured":"Gallo S, Vitacolonna A, Bonzano A, Comoglio P, Crepaldi T. ERK: A key player in the pathophysiology of cardiac hypertrophy. Int J Mol Sci. 2019;20. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31052420\/","DOI":"10.3390\/ijms20092164"},{"key":"1717_CR33","doi-asserted-by":"crossref","unstructured":"Niemeyer CM. RAS diseases in children. Haematologica. 2014. p. 1653\u201362.","DOI":"10.3324\/haematol.2014.114595"},{"key":"1717_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejmg.2005.03.001","volume":"48","author":"M Tartaglia","year":"2005","unstructured":"Tartaglia M, Gelb BD. Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet. 2005;48:81\u201396 Elsevier Masson","journal-title":"Eur J Med Genet"},{"key":"1717_CR35","doi-asserted-by":"crossref","unstructured":"Di Candia F, Marchetti V, Cirillo F, Di Minno A, Rosano C, Pagano S, et al. RASopathies and hemostatic abnormalities: key role of platelet dysfunction. Orphanet J Rare Dis. 2021;16:1\u20137. Available from: https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02122-7","DOI":"10.1186\/s13023-021-02122-7"},{"key":"1717_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00109-015-1346-3","volume":"94","author":"L Stefanini","year":"2016","unstructured":"Stefanini L, Bergmeier W. RAP1-GTPase signaling and platelet function. J Mol Med (Berl). 2016;94:13\u20139.","journal-title":"J Mol Med (Berl)"},{"key":"1717_CR37","doi-asserted-by":"crossref","unstructured":"Mason-Suares H, Toledo D, Gekas J, Lafferty KA, Meeks N, Pacheco MC, et al. Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome. Eur J Hum Genet. 2017;25:509\u201311. Available from: https:\/\/www.nature.com\/articles\/ejhg2016202","DOI":"10.1038\/ejhg.2016.202"},{"key":"1717_CR38","doi-asserted-by":"crossref","unstructured":"Fabretto A, Kutsche K, Harmsen MB, Demarini S, Gasparini P, Fertz MC, et al. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I. Eur J Med Genet. 2010;53:322\u20134. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20673819\/","DOI":"10.1016\/j.ejmg.2010.07.011"},{"key":"1717_CR39","doi-asserted-by":"crossref","unstructured":"Mussa A, Carli D, Giorgio E, Villar AM, Cardaropoli S, Carbonara C, et al. Mek inhibition in a newborn with raf1-associated noonan syndrome ameliorates hypertrophic cardiomyopathy but is insufficient to revert pulmonary vascular disease. Genes (Basel). 2022;13. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8774485\/","DOI":"10.3390\/genes13010006"},{"key":"1717_CR40","doi-asserted-by":"crossref","unstructured":"Chaput D, Andelfinger G. MEK Inhibition for RASopathy-Associated Hypertrophic Cardiomyopathy: Clinical Application of a Basic Concept. Can. J. Cardiol. Elsevier Inc.; 2024. p. 789\u201399. Available from: http:\/\/onlinecjc.ca\/article\/S0828282X24001855\/fulltext","DOI":"10.1016\/j.cjca.2024.02.020"},{"key":"1717_CR41","doi-asserted-by":"crossref","unstructured":"Juchnewitsch A-G, Pomm K, Dutta A, Tamp E, Valkna A, Lillepea K, et al. Undiagnosed RASopathies in infertile men. Front Endocrinol (Lausanne). 2024;15. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11035881\/","DOI":"10.3389\/fendo.2024.1312357"},{"key":"1717_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajmg.a.61429","volume":"182","author":"CL Lee","year":"2020","unstructured":"Lee CL, Tan LTHC, Lin HY, Hwu WL, Lee NC, Chien YH, et al. Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan. Am J Med Genet Part A. 2020;182:357\u201364.","journal-title":"Am J Med Genet Part A"},{"key":"1717_CR43","doi-asserted-by":"crossref","unstructured":"Zheng S, Huang H, Ma L, Zhu T. RASopathies due to de novo pathogenic variants: clinical features, genetic findings and outcomes in nine neonates born with congenital heart defects. BMC Med Genomics. 2022;15. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9400306\/","DOI":"10.1186\/s12920-022-01336-3"},{"key":"1717_CR44","doi-asserted-by":"crossref","unstructured":"Neven Q, Boulanger C, Bruwier A, de Ville de Goyet M, Meyts I, Moens L, et al. Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD). J Clin Immunol. 2021;41:51\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33011939\/","DOI":"10.1007\/s10875-020-00883-7"},{"key":"1717_CR45","doi-asserted-by":"crossref","unstructured":"Bastida P, Garc\u00eda-Mi\u00f1a\u00far S, Ezquieta B, Dapena JL, Sanchez De Toledo J. Myeloproliferative disorder in Noonan syndrome. J Pediatr Hematol Oncol. 2011;33. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20829714\/","DOI":"10.1097\/MPH.0b013e3181e7571e"},{"key":"1717_CR46","doi-asserted-by":"crossref","unstructured":"Hofmans M, Schr\u00f6der R, Lammens T, Flotho C, Niemeyer C, Van Roy N, et al. Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making. Br. J. Haematol. John Wiley & Sons, Ltd; 2019. p. E83\u20136. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/bjh.16191","DOI":"10.1111\/bjh.16191"},{"key":"1717_CR47","doi-asserted-by":"crossref","unstructured":"Gaipa G, Bugarin C, Cianci P, Sarno J, Bonaccorso P, Biondi A, et al. Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling. Blood Cancer J. 2015;5:e324. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4526778\/","DOI":"10.1038\/bcj.2015.52"},{"key":"1717_CR48","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.onc.1209845","volume":"26","author":"E Castellano","year":"2007","unstructured":"Castellano E, De Las RJ, Guerrero C, Santos E. Transcriptional networks of knockout cell lines identify functional specificities of H-Ras and N-Ras: Significant involvement of N-Ras in biotic and defense responses. Oncogene. 2007;26:917\u201333.","journal-title":"Oncogene"},{"key":"1717_CR49","doi-asserted-by":"crossref","unstructured":"Castellano E, Guerrero C, A N\u00fa\u00f1ez, De Las Rivas J, E Santos. Serum-dependent transcriptional networks identify distinct functional roles for H-Ras and N-Ras during initial stages of the cell cycle. Genome Biol. 2009;10. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19895680\/","DOI":"10.1186\/gb-2009-10-11-r123"},{"key":"1717_CR50","doi-asserted-by":"crossref","unstructured":"Azrak SS, Ginel-Picardo A, Drosten M, Barbacid M, Santos E. Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: Functional and mechanistic implications. BMC Genomics. 2013;14:1\u201330. Available from: https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/1471-2164-14-731","DOI":"10.1186\/1471-2164-14-731"},{"key":"1717_CR51","doi-asserted-by":"crossref","unstructured":"Wicik Z, Czajka P, Eyileten C, Fitas A, Wolska M, Jakubik D, et al. The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis. Platelets. 2022;33:1052\u201364. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/09537104.2022.2042233","DOI":"10.1080\/09537104.2022.2042233"},{"key":"1717_CR52","doi-asserted-by":"crossref","unstructured":"Patel P, Naik UP. Platelet MAPKs\u2014a 20+ year history: What do we really know? J. Thromb. Haemost. 2020. p. 2087\u2013102. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jth.14967","DOI":"10.1111\/jth.14967"},{"key":"1717_CR53","doi-asserted-by":"crossref","unstructured":"Pedriali G, Rimessi A, Sbano L, Giorgi C, Wieckowski MR, Previati M, et al. Regulation of endoplasmic reticulum\u2013mitochondria Ca2+ transfer and its importance for anti-cancer therapies. Front. Oncol. 2017. p. 180. Available from: www.frontiersin.org","DOI":"10.3389\/fonc.2017.00180"},{"key":"1717_CR54","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/blood-2017-11-742684","volume":"131","author":"K McArthur","year":"2018","unstructured":"McArthur K, Chappaz S, Kile BT. Apoptosis in megakaryocytes and platelets: the life and death of a lineage. Blood. 2018;131:605\u201310 Content Repository Only!","journal-title":"Blood"},{"key":"1717_CR55","doi-asserted-by":"crossref","unstructured":"Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost. 2006;4:2656\u201363. Available from:https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1538-7836.2006.02200.x","DOI":"10.1111\/j.1538-7836.2006.02200.x"},{"key":"1717_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.critrevonc.2014.11.002","volume":"93","author":"RM Thushara","year":"2015","unstructured":"Thushara RM, Hemshekhar M, Kemparaju K, Rangappa KS, Girish KS. Biologicals, platelet apoptosis and human diseases: An outlook. Crit Rev Oncol Hematol. 2015;93:149\u201358 Elsevier.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1717_CR57","doi-asserted-by":"crossref","unstructured":"Drosten M, Dhawahir A, Sum EYM, Urosevic J, Lechuga CG, Esteban LM, et al. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. EMBO J. 2010;29:1091\u2013104. Available from: www.embojournal.org","DOI":"10.1038\/emboj.2010.7"},{"key":"1717_CR58","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1182\/blood-2005-03-1062","volume":"106","author":"PJS Stork","year":"2005","unstructured":"Stork PJS, Dillon TJ. Multiple roles of Rap1 in hematopoietic cells: Complementary versus antagonistic functions. Blood. 2005;106:2952\u201361.","journal-title":"Blood."},{"key":"1717_CR59","doi-asserted-by":"crossref","unstructured":"Nussinov R, Jang H, Zhang M, Tsai CJ, Sablina AA. The Mystery of Rap1 Suppression of Oncogenic Ras. Trends in Cancer. NIH Public Access; 2020. p. 369\u201379. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7211489\/","DOI":"10.1016\/j.trecan.2020.02.002"},{"key":"1717_CR60","doi-asserted-by":"crossref","unstructured":"Devanand T, Venkatraman P, Vemparala S. Phosphorylation promotes binding affinity of Rap-Raf complex by allosteric modulation of switch loop dynamics. Sci Rep. 2018;8:12976. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6113251\/","DOI":"10.1038\/s41598-018-31234-7"},{"key":"1717_CR61","doi-asserted-by":"crossref","unstructured":"Kim D, Herdeis L, Rudolph D, Zhao Y, B\u00f6ttcher J, Vides A, et al. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature. 2023;619:160\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37258666\/","DOI":"10.1038\/s41586-023-06123-3"},{"key":"1717_CR62","doi-asserted-by":"crossref","unstructured":"Punekar SR, Velcheti V, Neel BG, Wong KK. The current state of the art and future trends in RAS-targeted cancer therapies. Nat. Rev. Clin. Oncol. Nature Publishing Group; 2022. p. 637\u201355. Available from: https:\/\/www.nature.com\/articles\/s41571-022-00671-9","DOI":"10.1038\/s41571-022-00671-9"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01717-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01717-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01717-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T15:02:38Z","timestamp":1718636558000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01717-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01717-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research included in this work has been approved by the University of Salamanca Ethics committee, and the Agriculture and Livestock Council, Junta de Castilla y Le\u00f3n (approval number 911).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}